| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. | Chief Operating Officer | Common Stock | 55,000 | $294,250 | $5.35 | 16 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122020153-ingalls-kerry-d-2022-03-16 | Poseida Therapeutics, Inc. | 16 Mar 2022 | 1 | +$11,940 | 4 | Chief Operating Officer | 18 Mar 2022, 20:01 |
| /report/000120919122014377-ingalls-kerry-d-2022-03-01 | Poseida Therapeutics, Inc. | 01 Mar 2022 | 2 | $0 | 4 | Chief Operating Officer | 01 Mar 2022, 18:29 |
| /report/000120919121065673-ingalls-kerry-d-2021-11-17 | Poseida Therapeutics, Inc. | 17 Nov 2021 | 1 | +$14,000 | 4 | Chief Operating Officer | 18 Nov 2021, 20:12 |